Kraft Heinz Co — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Kraft Heinz Co filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $8.31B | Feb 12, 2026 |
| FY2025 | Dec 28, 2024 | $8.97B | Feb 12, 2026 |
| FY2025 | Dec 30, 2023 | $8.93B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $8.12B | Feb 13, 2025 |
| FY2023 | Dec 25, 2021 | $8.68B | Feb 15, 2024 |
| FY2020 | Dec 26, 2020 | $2.52B | Feb 17, 2021 |
| FY2020 | Sep 26, 2020 | $2.34B | Feb 17, 2021 |
| FY2020 | Jun 27, 2020 | $2.45B | Feb 17, 2021 |
| FY2020 | Mar 28, 2020 | $1.86B | Feb 17, 2021 |
| FY2020 | Dec 28, 2019 | $2.11B | Feb 17, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | ($5.85B) | Feb 12, 2026 |
| FY2025 | Dec 28, 2024 | $2.74B | Feb 12, 2026 |
| FY2025 | Dec 30, 2023 | $2.86B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $2.36B | Feb 13, 2025 |
| FY2023 | Dec 25, 2021 | $1.01B | Feb 15, 2024 |
| FY2022 | Dec 26, 2020 | $356.00M | Feb 16, 2023 |
| FY2021 | Dec 28, 2019 | $1.94B | Feb 17, 2022 |
| FY2018 | Dec 29, 2018 | ($12.57B) | Jun 7, 2019 |
| FY2018 | Sep 29, 2018 | $619.00M | Jun 7, 2019 |
| FY2018 | Jun 30, 2018 | $754.00M | Jun 7, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | ($4.67B) | Feb 12, 2026 |
| FY2025 | Dec 28, 2024 | $1.68B | Feb 12, 2026 |
| FY2025 | Dec 30, 2023 | $4.57B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $3.63B | Feb 13, 2025 |
| FY2023 | Dec 25, 2021 | $3.46B | Feb 15, 2024 |
| FY2022 | Dec 26, 2020 | $2.13B | Feb 16, 2023 |
| FY2021 | Dec 28, 2019 | $3.07B | Feb 17, 2022 |
| FY2018 | Dec 29, 2018 | ($14.14B) | Jun 7, 2019 |
| FY2018 | Sep 29, 2018 | $1.07B | Jun 7, 2019 |
| FY2018 | Jun 30, 2018 | $1.34B | Jun 7, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $167.00M | Feb 12, 2026 |
| FY2025 | Dec 28, 2024 | $150.00M | Feb 12, 2026 |
| FY2025 | Dec 30, 2023 | $147.00M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $127.00M | Feb 13, 2025 |
| FY2023 | Dec 25, 2021 | $140.00M | Feb 15, 2024 |
| FY2022 | Dec 26, 2020 | $119.00M | Feb 16, 2023 |
| FY2021 | Dec 28, 2019 | $112.00M | Feb 17, 2022 |
| FY2020 | Dec 29, 2018 | $109.00M | Feb 17, 2021 |
| FY2019 | Dec 30, 2017 | $93.00M | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $120.00M | Jun 7, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $12.98B | Feb 12, 2026 |
| FY2025 | Dec 28, 2024 | $7.29B | Feb 12, 2026 |
| FY2025 | Dec 30, 2023 | $4.35B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $4.49B | Feb 13, 2025 |
| FY2023 | Dec 25, 2021 | $5.22B | Feb 15, 2024 |
| FY2022 | Dec 26, 2020 | $7.05B | Feb 16, 2023 |
| FY2021 | Dec 28, 2019 | $5.08B | Feb 17, 2022 |
| FY2018 | Dec 29, 2018 | $16.35B | Jun 7, 2019 |
| FY2018 | Sep 29, 2018 | $1.02B | Jun 7, 2019 |
| FY2018 | Jun 30, 2018 | $1.01B | Jun 7, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $4.46B | Feb 12, 2026 |
| FY2025 | Dec 28, 2024 | $4.18B | Feb 12, 2026 |
| FY2025 | Dec 30, 2023 | $3.98B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $2.47B | Feb 13, 2025 |
| FY2023 | Dec 25, 2021 | $5.36B | Feb 15, 2024 |
| FY2022 | Dec 26, 2020 | $4.93B | Feb 16, 2023 |
| FY2021 | Dec 28, 2019 | $3.55B | Feb 17, 2022 |
| FY2020 | Dec 29, 2018 | $2.57B | Feb 17, 2021 |
| FY2018 | Sep 29, 2018 | $878.00M | Jun 7, 2019 |
| FY2018 | Jun 30, 2018 | $216.00M | Jun 7, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $801.00M | Feb 12, 2026 |
| FY2025 | Dec 28, 2024 | $1.02B | Feb 12, 2026 |
| FY2025 | Dec 30, 2023 | $1.01B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $916.00M | Feb 13, 2025 |
| FY2023 | Dec 25, 2021 | $905.00M | Feb 15, 2024 |
| FY2022 | Dec 26, 2020 | $596.00M | Feb 16, 2023 |
| FY2021 | Dec 28, 2019 | $768.00M | Feb 17, 2022 |
| FY2020 | Dec 29, 2018 | $826.00M | Feb 17, 2021 |
| FY2018 | Sep 29, 2018 | $594.00M | Jun 7, 2019 |
| FY2018 | Jun 30, 2018 | $438.00M | Jun 7, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $81.79B | Feb 12, 2026 |
| FY2025 | Dec 28, 2024 | $88.29B | Feb 12, 2026 |
| FY2024 | Dec 30, 2023 | $90.34B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $90.51B | Feb 15, 2024 |
| FY2022 | Dec 25, 2021 | $93.39B | Feb 16, 2023 |
| FY2021 | Dec 26, 2020 | $99.83B | Feb 17, 2022 |
| FY2020 | Dec 28, 2019 | $101.45B | Feb 17, 2021 |
| FY2019 | Dec 29, 2018 | $103.46B | Feb 14, 2020 |
| FY2018 | Sep 29, 2018 | $119.58B | Jun 7, 2019 |
| FY2018 | Jun 30, 2018 | $121.75B | Jun 7, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $40.00B | Feb 12, 2026 |
| FY2025 | Dec 28, 2024 | $38.96B | Feb 12, 2026 |
| FY2024 | Dec 30, 2023 | $40.62B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $41.64B | Feb 15, 2024 |
| FY2022 | Dec 25, 2021 | $43.94B | Feb 16, 2023 |
| FY2021 | Dec 26, 2020 | $49.59B | Feb 17, 2022 |
| FY2020 | Dec 28, 2019 | $49.70B | Feb 17, 2021 |
| FY2019 | Dec 29, 2018 | $51.68B | Feb 14, 2020 |
| FY2018 | Sep 29, 2018 | $54.16B | Jun 7, 2019 |
| FY2018 | Jun 30, 2018 | $56.03B | Jun 7, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $41.66B | Feb 12, 2026 |
| FY2025 | Dec 28, 2024 | $49.19B | Feb 12, 2026 |
| FY2024 | Dec 30, 2023 | $49.53B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $48.68B | Feb 15, 2024 |
| FY2022 | Dec 25, 2021 | $49.30B | Feb 16, 2023 |
| FY2021 | Dec 26, 2020 | $50.10B | Feb 17, 2022 |
| FY2020 | Dec 28, 2019 | $51.62B | Feb 17, 2021 |
| FY2019 | Dec 29, 2018 | $51.66B | Feb 14, 2020 |
| FY2018 | Sep 29, 2018 | $65.22B | Jun 7, 2019 |
| FY2018 | Jun 30, 2018 | $65.52B | Jun 7, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $22.18B | Feb 12, 2026 |
| FY2025 | Dec 28, 2024 | $28.67B | Feb 12, 2026 |
| FY2025 | Dec 30, 2023 | $30.46B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $30.83B | Feb 13, 2025 |
| FY2023 | Dec 25, 2021 | $31.30B | Feb 15, 2024 |
| FY2022 | Dec 26, 2020 | $33.09B | Feb 16, 2023 |
| FY2020 | Dec 28, 2019 | $35.55B | Feb 17, 2021 |
| FY2019 | Dec 29, 2018 | $36.50B | Feb 14, 2020 |
| FY2018 | Sep 29, 2018 | $44.34B | Jun 7, 2019 |
| FY2018 | Jun 30, 2018 | $44.30B | Jun 7, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | ($4.63B) | Feb 12, 2026 |
| FY2025 | Dec 28, 2024 | $2.17B | Feb 12, 2026 |
| FY2024 | Dec 30, 2023 | $1.37B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $489.00M | Feb 15, 2024 |
| FY2022 | Dec 25, 2021 | ($1.68B) | Feb 16, 2023 |
| FY2021 | Dec 26, 2020 | ($2.69B) | Feb 17, 2022 |
| FY2020 | Dec 28, 2019 | ($3.06B) | Feb 17, 2021 |
| FY2019 | Dec 29, 2018 | ($4.85B) | Feb 14, 2020 |
| FY2018 | Sep 29, 2018 | $8.48B | Jun 7, 2019 |
| FY2018 | Jun 30, 2018 | $8.62B | Jun 7, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $2.62B | Feb 12, 2026 |
| FY2025 | Dec 28, 2024 | $1.33B | Feb 12, 2026 |
| FY2024 | Dec 30, 2023 | $1.40B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $1.04B | Feb 15, 2024 |
| FY2022 | Dec 25, 2021 | $3.45B | Feb 16, 2023 |
| FY2021 | Dec 26, 2020 | $3.42B | Feb 17, 2022 |
| FY2020 | Dec 28, 2019 | $2.28B | Feb 17, 2021 |
| FY2019 | Dec 29, 2018 | $1.13B | Feb 14, 2020 |
| FY2018 | Sep 29, 2018 | $1.37B | Jun 7, 2019 |
| FY2018 | Jun 30, 2018 | $3.37B | Jun 7, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | (4) | Feb 12, 2026 |
| FY2025 | Dec 28, 2024 | 2 | Feb 12, 2026 |
| FY2025 | Dec 30, 2023 | 2 | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 13, 2025 |
| FY2023 | Dec 25, 2021 | 0 | Feb 15, 2024 |
| FY2020 | Dec 26, 2020 | 0 | Feb 17, 2021 |
| FY2020 | Sep 26, 2020 | 0 | Feb 17, 2021 |
| FY2020 | Jun 27, 2020 | (1) | Feb 17, 2021 |
| FY2020 | Mar 28, 2020 | 0 | Feb 17, 2021 |
| FY2020 | Dec 28, 2019 | 0 | Feb 17, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | (4) | Feb 12, 2026 |
| FY2025 | Dec 28, 2024 | 2 | Feb 12, 2026 |
| FY2025 | Dec 30, 2023 | 2 | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 13, 2025 |
| FY2023 | Dec 25, 2021 | 0 | Feb 15, 2024 |
| FY2020 | Dec 26, 2020 | 0 | Feb 17, 2021 |
| FY2020 | Sep 26, 2020 | 0 | Feb 17, 2021 |
| FY2020 | Jun 27, 2020 | (1) | Feb 17, 2021 |
| FY2020 | Mar 28, 2020 | 0 | Feb 17, 2021 |
| FY2020 | Dec 28, 2019 | 0 | Feb 17, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | 1.18B | Feb 12, 2026 |
| FY2025 | Dec 28, 2024 | 1.20B | Feb 12, 2026 |
| FY2025 | Dec 30, 2023 | 1.22B | Feb 12, 2026 |
| FY2025 | Dec 31, 2022 | 1.23B | Feb 12, 2026 |
| FY2024 | Dec 25, 2021 | 1.22B | Feb 13, 2025 |
| FY2023 | Dec 26, 2020 | 1.22B | Feb 15, 2024 |
| FY2022 | Dec 28, 2019 | 1.22B | Feb 16, 2023 |
| FY2021 | Dec 29, 2018 | 1.22B | Feb 17, 2022 |
| FY2018 | Sep 29, 2018 | 1.22B | Jun 7, 2019 |
| FY2018 | Jun 30, 2018 | 1.22B | Jun 7, 2019 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 28, 2019 | $1.95B | Feb 14, 2020 |
| FY2019 | Dec 29, 2018 | $3.18B | Feb 14, 2020 |
| FY2018 | Sep 29, 2018 | $2.42B | Jun 7, 2019 |
| FY2018 | Jun 30, 2018 | $1.66B | Jun 7, 2019 |
| FY2018 | Mar 31, 2018 | $897.00M | Jun 7, 2019 |
| FY2019 | Dec 30, 2017 | $2.89B | Feb 14, 2020 |
| FY2018 | Sep 30, 2017 | $2.16B | Jun 7, 2019 |
| FY2018 | Jul 1, 2017 | $1.43B | Jun 7, 2019 |
| FY2018 | Apr 1, 2017 | $736.00M | Jun 7, 2019 |
| FY2018 | Dec 31, 2016 | $3.58B | Jun 7, 2019 |